We found that the expression of RIPK3, but not that of RIPK1, was progressively reduced during xenograft tumor growth in four out of five PDX samples derived from high-grade serous ovarian cancer biopsies (Fig 1D and 1E, S1A Fig). Here, RIPK3 is linked to ovarian serous adenocarcinoma.